BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 31907148)

  • 1. [Correlation between follicular fluid sRAGE level and ovarian responsiveness in non-PCOS patients undergoing controlled ovarian hyperstimulation].
    Li M; Shao Y; Fu H; Zhou C; Yao B; Tan Y
    Nan Fang Yi Ke Da Xue Xue Bao; 2019 Dec; 39(12):1482-1486. PubMed ID: 31907148
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Decreased levels of sRAGE in follicular fluid from patients with PCOS.
    Wang B; Li J; Yang Q; Zhang F; Hao M; Guo Y
    Reproduction; 2017 Mar; 153(3):285-292. PubMed ID: 27965400
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Follicular fluid soluble receptor for advanced glycation endproducts (sRAGE): a potential protective role in polycystic ovary syndrome.
    Wang B; Hao M; Yang Q; Li J; Guo Y
    J Assist Reprod Genet; 2016 Jul; 33(7):959-65. PubMed ID: 27011370
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Follicular fluid PlGF/sFlt-1 ratio and soluble receptor for advanced glycation end-products correlate with ovarian sensitivity index in women undergoing A.R.T.
    Nejabati HR; Mota A; Farzadi L; Ghojazadeh M; Fattahi A; Hamdi K; Nouri M
    J Endocrinol Invest; 2017 Feb; 40(2):207-215. PubMed ID: 27664102
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Follicular fluid soluble receptor for advanced glycation end-products (sRAGE): a potential indicator of ovarian reserve.
    Merhi Z; Irani M; Doswell AD; Ambroggio J
    J Clin Endocrinol Metab; 2014 Feb; 99(2):E226-33. PubMed ID: 24276462
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlation between follicular fluid levels of sRAGE and vitamin D in women with PCOS.
    Garg D; Grazi R; Lambert-Messerlian GM; Merhi Z
    J Assist Reprod Genet; 2017 Nov; 34(11):1507-1513. PubMed ID: 28825156
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum and follicular fluid levels of soluble receptor for advanced glycation end-products in women with and without polycystic ovary syndrome.
    Emami N; Alizadeh A; Maleki-Hajiagha A; Dizavi A; Vesali S; Moini A
    J Ovarian Res; 2023 Jun; 16(1):127. PubMed ID: 37391740
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Predictive value of anti-Mullerian hormone levels in serum and follicle fluid for IVF-ET outcomes in patients with polycystic ovarian syndrome].
    Chen X; Yin M; Ye D; He Y; Chen S
    Nan Fang Yi Ke Da Xue Xue Bao; 2013 Apr; 33(4):546-9. PubMed ID: 23644117
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Advanced glycation end product concentrations in follicular fluid of women undergoing IVF/ICSI with a GnRH agonist protocol.
    Yao Q; Liang Y; Shao Y; Bian W; Fu H; Xu J; Sui L; Yao B; Li M
    Reprod Biomed Online; 2018 Jan; 36(1):20-25. PubMed ID: 29174168
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intrafollicular soluble RAGE benefits embryo development and predicts clinical pregnancy in infertile patients of advanced maternal age undergoing in vitro fertilization.
    Li YJ; Chen JH; Sun P; Li JJ; Liang XY
    J Huazhong Univ Sci Technolog Med Sci; 2017 Apr; 37(2):243-247. PubMed ID: 28397051
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intrafollicular soluble receptor for advanced glycation end products (sRAGE) and embryo quality in assisted reproduction.
    Bonetti TC; Borges E; Braga DP; Iaconelli A; Kleine JP; Silva ID
    Reprod Biomed Online; 2013 Jan; 26(1):62-7. PubMed ID: 23182743
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-Müllerian hormone levels to predict oocyte maturity and embryo quality during controlled ovarian hyperstimulation.
    Melado Vidales L; Fernández-Nistal A; Martínez Fernández V; Verdú Merino V; Bruna Catalán I; Bajo Arenas JM
    Minerva Ginecol; 2017 Jun; 69(3):225-232. PubMed ID: 27352270
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Comparison of the efficiency between in-vitro maturation and in-vitro fertilization after early follicular phase GnRH agonist down-regulation in infertile women with polycystic ovary syndrome].
    Zhu RR; Xiao SQ; Zhao JZ; Lin J; Wang PY; Jin CC; Jin WM
    Zhonghua Fu Chan Ke Za Zhi; 2013 Nov; 48(11):833-7. PubMed ID: 24444560
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Smoothing Gan Reinforcing Shen Method Adjuvantly Treated Poor Response of Diminished Ovari- an Reserve Patients in in vitro Fertilization and Embryo Transfer: a Clinical Study].
    Zhang Z; Zhang XH; He TY
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2015 Oct; 35(10):1170-4. PubMed ID: 26677665
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum and follicular fluid leptin during in vitro fertilization: relationship among leptin increase, body fat mass, and reduced ovarian response.
    Bützow TL; Moilanen JM; Lehtovirta M; Tuomi T; Hovatta O; Siegberg R; Nilsson CG; Apter D
    J Clin Endocrinol Metab; 1999 Sep; 84(9):3135-9. PubMed ID: 10487676
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Concentrations of sRAGE in serum and follicular fluid in assisted reproductive cycles--a preliminary study.
    Malicková K; Jarosová R; Rezábek K; Fait T; Masata J; Janatková I; Zima T; Kalousová M
    Clin Lab; 2010; 56(9-10):377-84. PubMed ID: 21086782
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vascular endothelial growth factor and basic fibroblast growth factor in polycystic ovary syndrome during controlled ovarian hyperstimulation.
    Artini PG; Monti M; Matteucci C; Valentino V; Cristello F; Genazzani AR
    Gynecol Endocrinol; 2006 Aug; 22(8):465-70. PubMed ID: 17012110
    [TBL] [Abstract][Full Text] [Related]  

  • 18. sRAGE downregulates the VEGF expression in OHSS ovarian granulosa cells.
    Wang B; Wang J; Liu Y; Wang L; Du M; Zhang Z; Guan Y
    Gynecol Endocrinol; 2021 Sep; 37(9):836-840. PubMed ID: 34223781
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predicting the outcome of different protocols of in vitro fertilization with anti-Muüllerian hormone levels in patients with polycystic ovary syndrome.
    Chen Y; Ye B; Yang X; Zheng J; Lin J; Zhao J
    J Int Med Res; 2017 Jun; 45(3):1138-1147. PubMed ID: 28449632
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In-vitro maturation of oocytes vs in-vitro fertilization with a gonadotropin-releasing hormone antagonist for women with polycystic ovarian syndrome: can superiority be defined?
    Shavit T; Ellenbogen A; Michaeli M; Kartchovsky E; Ruzov O; Shalom-Paz E
    Eur J Obstet Gynecol Reprod Biol; 2014 Aug; 179():46-50. PubMed ID: 24965979
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.